Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Post by gmcsleon Nov 26, 2009 7:10pm
508 Views
Post# 16528267

When is this supposed to happen?

When is this supposed to happen?

The joint company will market the drug in Canada, Mexico, Central and South America, Israel and South Africa and will collect royalties on Paladin's sales in those regions. Paladin will receive royalties on future sales in other markets.

"Phase III clinical trials have just been completed on voclosporin for psoriasis and it has larger market potential in the tranplant area," said Jonathan Goodman, CEO of Paladin. "It provides us with another product to commercialize outside Canada, joining our growing international business. It may also lead to further co-operation with Isotechnika."

Bullboard Posts